Therefore, reference No 178 of Annex II and reference No 14 of Annex III, part 1 should be amended accordingly; reference No 382 of Annex II should be deleted and reference Nos 94 and 95 should be added in Annex III, part 1. (2) It is the opinion of the SCCNFP that the toxicological effects of the dialkanolamine salts, and, in particular, their readiness for nitrosamines' formation are similar to the respective properties of the dialkanolamines and that dialkylamines and their salts have very similar properties with the respective dialkanolamines' analogues with respect to nitrosamines' formation.
Therefore, reference No 411 of Annex II and reference Nos 60, 61 and 62 of Annex III, part 1, should be amended accordingly. (3) The SCCNFP has come to the conclusion that the compound 2,4-diamino-pyrimidine-3-oxide (CAS No 74638-76-9) can be used safely in cosmetic products at concentrations up to 1,5 %.
Member States shall take the necessary measures to ensure that from 24 March 2005 cosmetic products which fail to comply with this Directive shall not be placed on the market by Community manufacturers or by importers established within the Community. 2.
Member States shall take the necessary measures to ensure that the products referred to in paragraph 1 shall not be sold or disposed of to the final consumer after 24 September 2005.
Article 4 This Directive shall enter into force on the 20th day following that of its publication in the Official Journal of the European Union.
Article 5 This Directive is addressed to the Member States.
Done at Brussels, 24 September 2003.
For the Commission Erkki Liikanen Member of the Commission (1) OJ L 262, 27.9.1976, p. 169. (2) OJ L 224, 6.9.2003, p. 27.
